Log in

Genesis Healthcare Stock Forecast, Price & News

-0.02 (-3.77 %)
(As of 11/27/2020 12:00 AM ET)
Today's Range
Now: $0.51
50-Day Range
MA: $0.48
52-Week Range
Now: $0.51
Volume720,366 shs
Average Volume869,546 shs
Market Capitalization$85.07 million
P/E Ratio2.32
Dividend YieldN/A
Genesis Healthcare, Inc., together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services; Rehabilitation Therapy Services; and Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy. In addition, the company offers other specialty medical services, such as physician, staffing, and other healthcare related services. As of April 23, 2020, it provided inpatient services through a network of approximately 400 skilled nursing facilities and assisted/senior living communities in 25 states; and supplied rehabilitation and respiratory therapy to approximately 1,200 healthcare locations in 44 states, the District of Columbia and China. The company was formerly known as FC-GEN Operations Investment, LLC and changed its name to Genesis HealthCare, Inc. in February 2015. Genesis HealthCare, Inc. was founded in 2003 and is headquartered in Kennett Square, Pennsylvania.
Read More
Genesis Healthcare logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.36 out of 5 stars

Industry, Sector and Symbol

Industry Skilled nursing care facilities



Sales & Book Value

Annual Sales$4.57 billion
Cash Flow$0.96 per share
Book Value($6.57) per share


Net Income$14.62 million


Market Cap$85.07 million
Next Earnings Date3/15/2021 (Estimated)
-0.02 (-3.77 %)
(As of 11/27/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GEN News and Ratings via Email

Sign-up to receive the latest news and ratings for GEN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Genesis Healthcare (NYSE:GEN) Frequently Asked Questions

How has Genesis Healthcare's stock been impacted by Coronavirus?

Genesis Healthcare's stock was trading at $1.16 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, GEN stock has decreased by 56.0% and is now trading at $0.51.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Genesis Healthcare?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genesis Healthcare in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Genesis Healthcare

What stocks does MarketBeat like better than Genesis Healthcare?

Wall Street analysts have given Genesis Healthcare a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Genesis Healthcare wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Genesis Healthcare's next earnings date?

Genesis Healthcare is scheduled to release its next quarterly earnings announcement on Monday, March 15th 2021.
View our earnings forecast for Genesis Healthcare

How were Genesis Healthcare's earnings last quarter?

Genesis Healthcare, Inc. (NYSE:GEN) announced its quarterly earnings results on Monday, November, 9th. The company reported ($0.55) EPS for the quarter, missing the Zacks' consensus estimate of ($0.02) by $0.53. The firm earned $938.65 million during the quarter. Genesis Healthcare had a net margin of 1.07% and a negative return on equity of 5.06%.
View Genesis Healthcare's earnings history

What price target have analysts set for GEN?

1 brokerages have issued 1-year target prices for Genesis Healthcare's shares. Their forecasts range from $0.57 to $0.57. On average, they anticipate Genesis Healthcare's share price to reach $0.57 in the next twelve months. This suggests a possible upside of 11.8% from the stock's current price.
View analysts' price targets for Genesis Healthcare

Are investors shorting Genesis Healthcare?

Genesis Healthcare saw a increase in short interest in the month of October. As of October 15th, there was short interest totaling 1,150,000 shares, an increase of 21.4% from the September 30th total of 947,500 shares. Based on an average daily trading volume, of 1,230,000 shares, the days-to-cover ratio is currently 0.9 days. Currently, 2.1% of the shares of the company are short sold.
View Genesis Healthcare's Short Interest

Who are some of Genesis Healthcare's key competitors?

What other stocks do shareholders of Genesis Healthcare own?

Who are Genesis Healthcare's key executives?

Genesis Healthcare's management team includes the following people:
  • Mr. George V. Hager Jr., CEO & Director (Age 64, Pay $941.61k)
  • Mr. Thomas DiVittorio, Exec. VP & CFO (Age 52, Pay $525k)
  • Mr. Paul David Bach, COO & Exec. VP (Age 61, Pay $525k)
  • Mr. Michael Scott Sherman, Sr. VP, Gen. Counsel, Sec. & Assistant Treasurer (Age 51, Pay $380k)
  • Dr. JoAnne Susan Reifsnyder R.N., Ph.D., MSN, MBA, FAAN, Exec. VP of Clinical Operations & Chief Nursing Officer (Age 61, Pay $425k)
  • Mr. Richard L. Castor, Chief Information Officer & Sr. VP (Age 65)
  • Mr. James W. Tabak, Sr. VP of Admin. & Gov. Affairs (Age 61)
  • Ms. Lori Mayer, VP of Investor Relations, Brand Management & Marketing Communications
  • Mr. Larry Baider, Sr. VP of People Strategy & Operations
  • Mr. Jason Hadley Feuerman, Sr. VP of Strategic Devel. & Managed Care

What is Genesis Healthcare's stock symbol?

Genesis Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "GEN."

Who are Genesis Healthcare's major shareholders?

Genesis Healthcare's stock is owned by a number of institutional and retail investors. Top institutional investors include Acadian Asset Management LLC (1.25%), Squarepoint Ops LLC (0.16%), First Trust Advisors LP (0.09%) and Jane Street Group LLC (0.08%). Company insiders that own Genesis Healthcare stock include George V Hager, Jr, Joanne Susan Reifsnyder, Michael Scott Sherman, Paul David Bach, Stephen Scott Young and Thomas Divittorio.
View institutional ownership trends for Genesis Healthcare

Which institutional investors are selling Genesis Healthcare stock?

GEN stock was sold by a variety of institutional investors in the last quarter, including Jane Street Group LLC. Company insiders that have sold Genesis Healthcare company stock in the last year include George V Hager, Jr, Joanne Susan Reifsnyder, Paul David Bach, Stephen Scott Young, and Thomas Divittorio.
View insider buying and selling activity for Genesis Healthcare

Which institutional investors are buying Genesis Healthcare stock?

GEN stock was bought by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Squarepoint Ops LLC, and First Trust Advisors LP.
View insider buying and selling activity for Genesis Healthcare

How do I buy shares of Genesis Healthcare?

Shares of GEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Genesis Healthcare's stock price today?

One share of GEN stock can currently be purchased for approximately $0.51.

How big of a company is Genesis Healthcare?

Genesis Healthcare has a market capitalization of $85.07 million and generates $4.57 billion in revenue each year. Genesis Healthcare employs 55,000 workers across the globe.

What is Genesis Healthcare's official website?

The official website for Genesis Healthcare is www.genesishcc.com.

How can I contact Genesis Healthcare?

Genesis Healthcare's mailing address is 101 EAST STATE STREET, KENNETT SQUARE PA, 19348. The company can be reached via phone at 610-444-6350 or via email at [email protected]

This page was last updated on 11/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.